TapewireFind a company

person · Reporting owner

Henderson Jeffrey William

Disclosed activity across 4 companies

Tapewire entity
14817
SEC CIK
0001324015

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
BECTON DICKINSON & COBDX · Entity 2498DirectorJanuary 27, 2026January 29, 2026
HALOZYME THERAPEUTICS, INC.HALO · Entity 793DirectorMay 05, 2026May 07, 2026
KYNTRA BIO, INC.FGEN · Entity 7431DirectorSeptember 01, 2023September 07, 2023
QUALCOMM INC/DEQCOM · Entity 2852DirectorMarch 17, 2026March 18, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

BECTON DICKINSON & CO

Report date January 27, 2026 · Filed January 29, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect9,143 Reported balance After 2026-01-27 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2026-01-27 · Grant · Acquired 1,098 · Balance 9,143

F1: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

F2: Includes units acquired through dividend investment since the last report filed by the reporting person.

Common StockSEC Table I · non-derivativeIndirectBy wife15 Reported balance Holding disclosure · report date 2026-01-27 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 15

Filing footnotes · ownership attribution and instrument terms

F1: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

F2: Includes units acquired through dividend investment since the last report filed by the reporting person.

HALOZYME THERAPEUTICS, INC.

Report date May 05, 2026 · Filed May 07, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect36,572 Reported balance After 2026-05-05 transaction · row 1
1 source row

Row 1 · 2026-05-05 · Grant · Acquired 3,796 · Balance 36,572

F1: Represents annual restricted stock unit ("RSU") grant under the Issuer's director compensation program. Each RSU represents the right to receive one share of common stock of the Issuer. This grant will vest in full on the earlier of (i) May 5, 2027 and (ii) the date of the Issuer's next annual meeting of stockholders.

Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $65.87 · Expires 2036-05-05Direct6,040 Reported balance After 2026-05-05 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2026-05-05 · Grant · Acquired 6,040 · Balance 6,040

F2: Represents annual stock option grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 5, 2027 and (ii) the date of the Issuer's next annual meeting of stockholders.

Filing footnotes · ownership attribution and instrument terms

F1: Represents annual restricted stock unit ("RSU") grant under the Issuer's director compensation program. Each RSU represents the right to receive one share of common stock of the Issuer. This grant will vest in full on the earlier of (i) May 5, 2027 and (ii) the date of the Issuer's next annual meeting of stockholders.

F2: Represents annual stock option grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 5, 2027 and (ii) the date of the Issuer's next annual meeting of stockholders.

KYNTRA BIO, INC.

Report date September 01, 2023 · Filed September 07, 2023

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect28,866 Reported balance After 2023-09-01 transaction · row 1
1 source row

Row 1 · 2023-09-01 · Sale · Disposed 2,000 · Balance 28,866

F1: Shares sold by the reporting person pursuant to a 10b5-1 trading plan dated March 3, 2023.

F2: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $0.970 to $1.075. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Filing footnotes · ownership attribution and instrument terms

F1: Shares sold by the reporting person pursuant to a 10b5-1 trading plan dated March 3, 2023.

F2: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $0.970 to $1.075. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

QUALCOMM INC/DE

Report date March 17, 2026 · Filed March 18, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect14,598.6901 Reported balance After 2026-03-17 transaction · row 1
1 source row

Row 1 · 2026-03-17 · Grant · Acquired 2,563 · Balance 14,598.6901

F1: Represents the grant of Annual Deferred Stock Units to Directors pursuant to the Qualcomm Incorporated 2026 Director Compensation Plan. Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) March 17, 2029 (2) death, (3) disability, or (4) a change in control. If an election is made to settle the units partially in cash, such partial cash settlement will be reported on a subsequent Form 4 (if applicable) as a disposition to the Issuer on the settlement date.

Filing footnotes · ownership attribution and instrument terms

F1: Represents the grant of Annual Deferred Stock Units to Directors pursuant to the Qualcomm Incorporated 2026 Director Compensation Plan. Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) March 17, 2029 (2) death, (3) disability, or (4) a change in control. If an election is made to settle the units partially in cash, such partial cash settlement will be reported on a subsequent Form 4 (if applicable) as a disposition to the Issuer on the settlement date.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
March 12, 2022 Filed Mar 15, 2022 20:08 UTC QUALCOMM INC/DE QCOM · Entity 2852 Disposition to issuerCommon Stock 1,469 $152.34 $223,787.46
Disclosure

SEC source: 0001888316-22-000022 · edgardoc.xml · nonDerivative · entry 2

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,105

Read SEC document
March 12, 2022 Filed Mar 15, 2022 20:08 UTC QUALCOMM INC/DE QCOM · Entity 2852 Exercise / conversionCommon Stock 4,559 $0.00 $0.00
Disclosure

SEC source: 0001888316-22-000022 · edgardoc.xml · nonDerivative · entry 1

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,574

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 09, 2022 Filed Mar 11, 2022 21:10 UTC QUALCOMM INC/DE QCOM · Entity 2852 GrantDeferred Stock Unit · Derivative 1,774 $0.00 $0.00
Disclosure

SEC source: 0001888316-22-000017 · edgardoc.xml · derivative · entry 1

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,485.6415

Underlying: Common Stock · 1,774 shares

Expires not disclosed

F1 · security: Represents the grant of Annual Deferred Stock Units to Directors pursuant to the Qualcomm Incorporated 2022 Director Compensation Plan.

F2 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control.

F3 · derivative.expiration_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control.

Read SEC document
January 25, 2022 Filed Jan 26, 2022 18:44 UTC BECTON DICKINSON & CO BDX · Entity 2498 GrantCommon Stock 820 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-001583 · form4.xml · nonDerivative · entry 1

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,777

F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

F2 · balance_after: Includes units acquired through dividend reinvestment since the last report filed by the reporting person.

Read SEC document
May 26, 2021 Filed May 28, 2021 23:05 UTC KYNTRA BIO, INC. FGEN · Entity 7431 GrantStock Option (Right to Buy) · Derivative 7,800 $0.00 Strike: $20.86 $0.00
Disclosure

SEC source: 0001209191-21-036677 · doc4.xml · derivative · entry 2

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,800

Underlying: Common Stock · 7,800 shares

Expires 2031-05-25

F2 · derivative.exercise_date: Options vest on the earlier of May 26, 2022 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date.

Read SEC document
May 26, 2021 Filed May 28, 2021 23:05 UTC KYNTRA BIO, INC. FGEN · Entity 7431 GrantCommon Stock 4,700 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-036677 · doc4.xml · nonDerivative · entry 1

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,800

F1 · shares: Represents the grant of restricted stock units that vest on the earlier of May 26, 2022 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date.

Read SEC document
May 05, 2021 Filed May 7, 2021 00:02 UTC HALOZYME THERAPEUTICS, INC. HALO · Entity 793 GrantRestricted Stock Units 5,230 $0.00 $0.00
Disclosure

SEC source: 0001179110-21-004972 · edgar.xml · nonDerivative · entry 1

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,839

F1 · shares: Represents annual restricted stock unit grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 5, 2022 and (ii) the date of the Issuer's next annual meeting of stockholders.

Read SEC document
April 05, 2021 Filed Apr 6, 2021 20:29 UTC QUALCOMM INC/DE QCOM · Entity 2852 Exercise / conversionDeferred Stock Unit · Derivative 4,134.6854 $0.00 $0.00
Disclosure

SEC source: 0001205233-21-000026 · edgardoc.xml · derivative · entry 3

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,578.6065

Underlying: Common Stock · 4,134.6854 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of the Company's common stock.

F2 · derivative.exercise_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control.

F2 · derivative.expiration_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control.

Read SEC document
April 05, 2021 Filed Apr 6, 2021 20:29 UTC QUALCOMM INC/DE QCOM · Entity 2852 Disposition to issuerCommon Stock 1,333 $140.33 $187,059.89
Disclosure

SEC source: 0001205233-21-000026 · edgardoc.xml · nonDerivative · entry 2

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,015

Read SEC document
April 05, 2021 Filed Apr 6, 2021 20:29 UTC QUALCOMM INC/DE QCOM · Entity 2852 Exercise / conversionCommon Stock 4,134 $0.00 $0.00
Disclosure

SEC source: 0001205233-21-000026 · edgardoc.xml · nonDerivative · entry 1

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,348

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 10, 2021 Filed Mar 11, 2021 23:19 UTC QUALCOMM INC/DE QCOM · Entity 2852 GrantDeferred Stock Unit · Derivative 1,922 $0.00 $0.00
Disclosure

SEC source: 0001205233-21-000008 · edgardoc.xml · derivative · entry 1

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,653.3815

Underlying: Common Stock · 1,922 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of the Company's common stock.

F2 · derivative.exercise_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control.

F2 · derivative.expiration_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control.

Read SEC document
January 26, 2021 Filed Jan 28, 2021 14:02 UTC BECTON DICKINSON & CO BDX · Entity 2498 GrantCommon Stock 829 $0.00 $0.00
Disclosure

SEC source: 0001543407-21-000008 · edgar.xml · nonDerivative · entry 1

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,918

F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

F2 · balance_after: Includes units acquired through dividend reinvestment since the last report filed by the reporting person.

Read SEC document
November 25, 2020 Filed Nov 25, 2020 23:59 UTC HALOZYME THERAPEUTICS, INC. HALO · Entity 793 SaleCommon Stock 24,498 $40.08 $981,757.35
Disclosure

SEC source: 0001179110-20-011428 · edgar.xml · nonDerivative · entry 1

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,609

F1 · price: Represents a weighted average sales price per share. These shares were sold at prices ranging from $40.07 to $40.11. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
November 10, 2020 Filed Nov 12, 2020 21:03 UTC QUALCOMM INC/DE QCOM · Entity 2852 SaleCommon Stock 6,000 $141.10 $846,602.40
Disclosure

SEC source: 0001205233-20-000071 · edgardoc.xml · nonDerivative · entry 1

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,214

F1 · price: The sale prices for this transaction ranged from $140.80 to $141.48. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
June 04, 2020 Filed Jun 9, 2020 00:26 UTC KYNTRA BIO, INC. FGEN · Entity 7431 GrantStock Option (Right to Buy) · Derivative 7,800 $0.00 Strike: $32.69 $0.00
Disclosure

SEC source: 0001209191-20-035148 · doc4.xml · derivative · entry 2

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,800

Underlying: Common Stock · 7,800 shares

Expires 2030-06-03

F2 · derivative.exercise_date: Options vest on the earlier of June 4, 2021 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date.

Read SEC document
June 04, 2020 Filed Jun 9, 2020 00:26 UTC KYNTRA BIO, INC. FGEN · Entity 7431 GrantCommon Stock 4,700 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-035148 · doc4.xml · nonDerivative · entry 1

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,100

F1 · shares: Represents the grant of restricted stock units that vest on the earlier of June 4, 2021 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date.

Read SEC document
April 30, 2020 Filed May 1, 2020 23:12 UTC HALOZYME THERAPEUTICS, INC. HALO · Entity 793 GrantCommon Stock 8,829 $0.00 $0.00
Disclosure

SEC source: 0001179110-20-005378 · edgar.xml · nonDerivative · entry 1

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,107

F1 · shares: Represents annual restricted stock grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) April 30, 2021 or (ii) the date of the Issuer's next annual meeting of stockholders.

Read SEC document
March 10, 2020 Filed Mar 12, 2020 20:19 UTC QUALCOMM INC/DE QCOM · Entity 2852 GrantDeferred Stock Unit · Derivative 3,107 $0.00 $0.00
Disclosure

SEC source: 0001205233-20-000017 · edgardoc.xml · derivative · entry 4

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,454.0584

Underlying: Common Stock · 3,107 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of the Company's common stock.

F2 · derivative.exercise_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control.

F2 · derivative.expiration_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control.

Read SEC document
March 10, 2020 Filed Mar 12, 2020 20:19 UTC QUALCOMM INC/DE QCOM · Entity 2852 Exercise / conversionDeferred Stock Unit · Derivative 4,644.6165 $0.00 $0.00
Disclosure

SEC source: 0001205233-20-000017 · edgardoc.xml · derivative · entry 3

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,347.0584

Underlying: Common Stock · 4,644.6165 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of the Company's common stock.

F2 · derivative.exercise_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control.

F2 · derivative.expiration_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control.

Read SEC document
March 10, 2020 Filed Mar 12, 2020 20:19 UTC QUALCOMM INC/DE QCOM · Entity 2852 Disposition to issuerCommon Stock 1,497 $78.89 $118,098.33
Disclosure

SEC source: 0001205233-20-000017 · edgardoc.xml · nonDerivative · entry 2

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,214

Read SEC document
March 10, 2020 Filed Mar 12, 2020 20:19 UTC QUALCOMM INC/DE QCOM · Entity 2852 Exercise / conversionCommon Stock 4,644 $0.00 $0.00
Disclosure

SEC source: 0001205233-20-000017 · edgardoc.xml · nonDerivative · entry 1

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,711

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 28, 2020 Filed Jan 30, 2020 13:33 UTC BECTON DICKINSON & CO BDX · Entity 2498 GrantCommon Stock 765 $0.00 $0.00
Disclosure

SEC source: 0001543407-20-000013 · edgar.xml · nonDerivative · entry 1

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,089

F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

F2 · balance_after: Includes units acquired through dividend reinvestment since the last report filed by the reporting person.

Read SEC document
June 05, 2019 Filed Jun 7, 2019 22:54 UTC KYNTRA BIO, INC. FGEN · Entity 7431 GrantStock Option (Right to Buy) · Derivative 7,800 $0.00 Strike: $39.03 $0.00
Disclosure

SEC source: 0001209191-19-035651 · doc4.xml · derivative · entry 2

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,800

Underlying: Common Stock · 7,800 shares

Expires 2029-06-05

F2 · derivative.exercise_date: Options vest on the earlier of June 5, 2020 or the date of the next annual meeting of stockholders.

Read SEC document
June 05, 2019 Filed Jun 7, 2019 22:54 UTC KYNTRA BIO, INC. FGEN · Entity 7431 GrantCommon Stock 4,700 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-035651 · doc4.xml · nonDerivative · entry 1

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,400

F1 · shares: Represents the grant of restricted stock units that vest on the earlier of June 5, 2020 or the date of the next annual meeting of stockholders.

Read SEC document
May 02, 2019 Filed May 3, 2019 20:15 UTC HALOZYME THERAPEUTICS, INC. HALO · Entity 793 GrantCommon Stock 12,173 $0.00 $0.00
Disclosure

SEC source: 0001179110-19-005504 · edgar.xml · nonDerivative · entry 1

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,278

F1 · shares: Represents annual restricted stock grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 2, 2020 or (ii) the date of the Issuer's next annual meeting of stockholders.

Read SEC document
March 12, 2019 Filed Mar 14, 2019 22:59 UTC QUALCOMM INC/DE QCOM · Entity 2852 GrantDeferred Stock Unit · Derivative 4,241 $0.00 $0.00
Disclosure

SEC source: 0001205233-19-000024 · edgardoc.xml · derivative · entry 1

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,567.6725

Underlying: Common Stock · 4,241 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of the Company's common stock.

F2 · derivative.exercise_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control.

F2 · derivative.expiration_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control.

Read SEC document
March 08, 2019 Filed Mar 12, 2019 20:26 UTC QUALCOMM INC/DE QCOM · Entity 2852 Exercise / conversionDeferred Stock Unit · Derivative 5,099.4055 $0.00 $0.00
Disclosure

SEC source: 0001205233-19-000015 · edgardoc.xml · derivative · entry 3

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,326.6725

Underlying: Common Stock · 5,099.4055 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of the Company's common stock.

F2 · derivative.exercise_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control.

F2 · derivative.expiration_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control.

Read SEC document
March 08, 2019 Filed Mar 12, 2019 20:26 UTC QUALCOMM INC/DE QCOM · Entity 2852 Disposition to issuerCommon Stock 1,644 $53.53 $88,003.32
Disclosure

SEC source: 0001205233-19-000015 · edgardoc.xml · nonDerivative · entry 2

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,067

Read SEC document
March 08, 2019 Filed Mar 12, 2019 20:26 UTC QUALCOMM INC/DE QCOM · Entity 2852 Exercise / conversionCommon Stock 5,099 $0.00 $0.00
Disclosure

SEC source: 0001205233-19-000015 · edgardoc.xml · nonDerivative · entry 1

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,711

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 22, 2019 Filed Jan 24, 2019 14:50 UTC BECTON DICKINSON & CO BDX · Entity 2498 GrantCommon Stock 923 $0.00 $0.00
Disclosure

SEC source: 0001543407-19-000006 · edgar.xml · nonDerivative · entry 1

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,310

F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

F2 · balance_after: Includes units acquired through dividend reinvestment since the last report filed by the reporting person.

Read SEC document
June 05, 2018 Filed Jun 7, 2018 23:28 UTC KYNTRA BIO, INC. FGEN · Entity 7431 GrantStock Option (Right to Buy) · Derivative 6,000 $0.00 Strike: $55.30 $0.00
Disclosure

SEC source: 0001209191-18-036510 · doc4.xml · derivative · entry 2

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,000

Underlying: Common Stock · 6,000 shares

Expires 2028-06-05

F2 · derivative.exercise_date: Options vest on the earlier of June 6, 2019 or the date of the next annual meeting of stockholders.

Read SEC document
June 05, 2018 Filed Jun 7, 2018 23:28 UTC KYNTRA BIO, INC. FGEN · Entity 7431 GrantCommon Stock 3,700 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-036510 · doc4.xml · nonDerivative · entry 1

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,700

F1 · shares: Represents the grant of restricted stock units that vest on the earlier of June 6, 2019 or the date of the next annual meeting of stockholders.

Read SEC document
May 02, 2018 Filed May 2, 2018 23:40 UTC HALOZYME THERAPEUTICS, INC. HALO · Entity 793 GrantCommon Stock 10,363 $0.00 $0.00
Disclosure

SEC source: 0001179110-18-006088 · edgar.xml · nonDerivative · entry 1

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,105

F1 · shares: Represents annual restricted stock grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 2, 2019 or (ii) the date of the Issuer's next annual meeting of stockholders.

Read SEC document
April 05, 2018 Filed Apr 9, 2018 20:49 UTC QUALCOMM INC/DE QCOM · Entity 2852 GrantDeferred Stock Unit · Derivative 3,758 $0.00 $0.00
Disclosure

SEC source: 0001205233-18-000020 · edgardoc.xml · derivative · entry 1

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,972.716

Underlying: Common Stock · 3,758 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of the Company's common stock.

F2 · derivative.exercise_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control.

F2 · derivative.expiration_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control.

Read SEC document
March 22, 2018 Filed Mar 26, 2018 21:06 UTC QUALCOMM INC/DE QCOM · Entity 2852 Exercise / conversionDeferred Stock Unit · Derivative 795.3308 $0.00 $0.00
Disclosure

SEC source: 0001205233-18-000007 · edgardoc.xml · derivative · entry 3

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,214.716

Underlying: Common Stock · 795.3308 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of the Company's common stock.

F2 · derivative.exercise_date: Deferred Stock Units are 100% vested on the earlier of (1) the one-year anniversary of the grant date, (2) the date of the next annual meeting of stockholders of the Company that occurs after the grant date, (3) death, (4) disability, or (5) a change in control. The units will be settled in shares of the Company's common stock or cash in accordance with the grant agreement on the earlier of (1) March 9, 2018, (2) separation from service, (3) death, (4) disability, or (5) a change in control.

F2 · derivative.expiration_date: Deferred Stock Units are 100% vested on the earlier of (1) the one-year anniversary of the grant date, (2) the date of the next annual meeting of stockholders of the Company that occurs after the grant date, (3) death, (4) disability, or (5) a change in control. The units will be settled in shares of the Company's common stock or cash in accordance with the grant agreement on the earlier of (1) March 9, 2018, (2) separation from service, (3) death, (4) disability, or (5) a change in control.

Read SEC document
March 22, 2018 Filed Mar 26, 2018 21:06 UTC QUALCOMM INC/DE QCOM · Entity 2852 Disposition to issuerCommon Stock 257 $55.58 $14,284.06
Disclosure

SEC source: 0001205233-18-000007 · edgardoc.xml · nonDerivative · entry 2

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 612

Read SEC document
March 22, 2018 Filed Mar 26, 2018 21:06 UTC QUALCOMM INC/DE QCOM · Entity 2852 Exercise / conversionCommon Stock 795 $0.00 $0.00
Disclosure

SEC source: 0001205233-18-000007 · edgardoc.xml · nonDerivative · entry 1

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 869

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 07, 2017 Filed Jun 9, 2017 22:38 UTC KYNTRA BIO, INC. FGEN · Entity 7431 GrantStock Option (Right to Buy) · Derivative 12,000 $0.00 Strike: $28.65 $0.00
Disclosure

SEC source: 0001209191-17-038998 · doc4.xml · derivative · entry 1

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2027-06-07

F1 · derivative.exercise_date: The shares subject to the option vest and become exercisable quarterly over one year measured from June 7, 2017.

Read SEC document
May 04, 2017 Filed May 5, 2017 20:55 UTC HALOZYME THERAPEUTICS, INC. HALO · Entity 793 GrantCommon Stock 14,135 $0.00 $0.00
Disclosure

SEC source: 0001179110-17-006695 · edgar.xml · nonDerivative · entry 1

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,742

F1 · shares: Represents annual restricted stock grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 4, 2018 or (ii) the date of the Issuer's next annual meeting of stockholders.

Read SEC document
March 07, 2017 Filed Mar 9, 2017 21:21 UTC QUALCOMM INC/DE QCOM · Entity 2852 GrantDeferred Stock Unit · Derivative 4,154 $0.00 $0.00
Disclosure

SEC source: 0001234452-17-000039 · edgardoc.xml · derivative · entry 1

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,569.9096

Underlying: Common Stock · 4,154 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of the Company's common stock.

F2 · derivative.exercise_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control.

F2 · derivative.expiration_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control.

Read SEC document
March 08, 2016 Filed Mar 10, 2016 18:28 UTC QUALCOMM INC/DE QCOM · Entity 2852 GrantDeferred Stock Unit · Derivative 4,539 $0.00 $0.00
Disclosure

SEC source: 0001234452-16-000381 · edgardoc.xml · derivative · entry 1

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,270

Underlying: Common Stock · 4,539 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of the Company's common stock.

F2 · derivative.exercise_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control.

F2 · derivative.expiration_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control.

Read SEC document
January 12, 2016 Filed Jan 14, 2016 21:55 UTC QUALCOMM INC/DE QCOM · Entity 2852 GrantDeferred Stock Unit · Derivative 731 $0.00 $0.00
Disclosure

SEC source: 0001234452-16-000335 · edgardoc.xml · derivative · entry 1

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 731

Underlying: Common Stock · 731 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred stock unit represents a right to receive one share of the Company's common stock.

F2 · derivative.exercise_date: Deferred Stock Units are 100% vested on the earlier of (1) the one-year anniversary of the grant date, (2) the date of the next annual meeting of stockholders of the Company that occurs after the grant date, (3) death, (4) disability, or (5) a change in control. The units will be settled in shares of the Company's common stock or cash in accordance with the grant agreement on the earlier of (1) March 9, 2018, (2) separation from service, (3) death, (4) disability, or (5) a change in control.

F2 · derivative.expiration_date: Deferred Stock Units are 100% vested on the earlier of (1) the one-year anniversary of the grant date, (2) the date of the next annual meeting of stockholders of the Company that occurs after the grant date, (3) death, (4) disability, or (5) a change in control. The units will be settled in shares of the Company's common stock or cash in accordance with the grant agreement on the earlier of (1) March 9, 2018, (2) separation from service, (3) death, (4) disability, or (5) a change in control.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.